Delivery Order SPE2DB22D1017-SPE2DB25FF8MK

Award Date 3/25/25
Potential Completion Date 3/26/25
Potential Value $3.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $2,457.00 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of XULANE 150-35 MCG/DAY PATCH 3S, a contraceptive patch, with a period of performance through June 10, 2025. The contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract...
This is a $1,571.52 firm-fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for XULANE 150-35 MCG/DAY PATCH 3S, a prescription contraceptive patch. The contract has an ultimate completion date of June 13, 2025 and is not set aside for any specific business type. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This is a $6,106.38 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XULANE, a 150-35 mcg/day contraceptive patch, and has a period of performance through June 12, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,836.84 firm fixed-price contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a transdermal contraceptive patch, with a completion date of February 20, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,746.23 contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a contraceptive medication. The award has an ultimate completion date of July 5, 2023 and is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,630.49 fixed-price delivery order is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a prescription contraceptive medication. The contract has an ultimate completion date of January 5, 2024 and was awarded on January 4, 2024. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,951.68, is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a contraceptive medication. The delivery order has an ultimate completion date of October 22, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $8,064.59 contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a prescription contraceptive patch. The award has a completion date of September 25, 2024 and does not utilize any set-aside designations. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with DLA Troop Support Medical and the Department...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,401.56, is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a contraceptive patch product. The period of performance runs through October 21, 2024. The award is part of AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a contraceptive patch. The award has a ceiling value of $1,673.55 and a period of performance ending on May 2, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF8MK
    Delivery Order

This is a $3,296.63 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of XULANE 150-35 MCG/DAY PATCH 3S, a contraceptive patch, with a period of performance through March 26, 2025.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This delivery order is issued under that larger IDC contract. The contract does not have a set-aside designation, indicating open competition.

Generated 6/24/25, 9:43 AM